Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.01% | 30.55% | 34.29% | 34.65% | 33.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.01% | 30.55% | 34.29% | 34.65% | 33.36% |
| Cost of Revenue | -7.60% | 2.82% | 7.73% | 6.14% | 3.66% |
| Gross Profit | 21.76% | 33.58% | 37.33% | 38.25% | 37.45% |
| SG&A Expenses | 13.95% | 20.59% | 23.36% | 29.59% | 27.71% |
| Depreciation & Amortization | 13.74% | -24.18% | -27.48% | -22.23% | -15.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.47% | 17.09% | 18.76% | 23.02% | 20.60% |
| Operating Income | 491.65% | 160.98% | 117.36% | 81.13% | 87.60% |
| Income Before Tax | -27.21% | 34.56% | 28.33% | -25.48% | -3.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.21% | 34.56% | 28.33% | -25.48% | -3.02% |
| Earnings from Discontinued Operations | -516.22% | -1,158.67% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -91.26% | -94.03% | -95.08% | -79.65% | -54.79% |
| Net Income | -288.66% | -348.29% | -51.36% | -133.72% | -124.59% |
| EBIT | 491.65% | 160.98% | 117.36% | 81.13% | 87.60% |
| EBITDA | 186.02% | 549.02% | 225.24% | 158.08% | 163.90% |
| EPS Basic | -282.11% | -339.97% | -49.09% | -128.37% | -118.26% |
| Normalized Basic EPS | 3.63% | 59.46% | 55.71% | 30.40% | 49.76% |
| EPS Diluted | -272.26% | -328.60% | -49.09% | -128.37% | -118.26% |
| Normalized Diluted EPS | 2.96% | 59.12% | 55.71% | 30.40% | 49.76% |
| Average Basic Shares Outstanding | 1.08% | 1.70% | 1.87% | 2.18% | 2.48% |
| Average Diluted Shares Outstanding | 1.94% | 2.57% | 1.87% | 2.18% | 2.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |